news Drug candidate outperforms remdesivir as COVID-19 antiviral in cell assays 18 August 2020 | By Victoria Rees (Drug Target Review) A compound called BOLD-100, which has shown efficacy against COVID-19 in pre-clinical trials, has now outperformed remdesivir in a cytopathic effect assay.
news Novel antiviral compound proposed as COVID-19 therapeutic 30 March 2020 | By Victoria Rees (Drug Target Review) A molecule called BOLD-100, developed to fight cancer, has been suggested as a therapeutic to combat the COVID-19 coronavirus due to its antiviral properties.